Taken together, our data indicate that: (1) both HFCS and SUC can promote adipose tissues pro-inflammatory F4/80+CD11c+ macrophage infiltration, leading to adipose inflammation and insulin resistance; (2) HFCS and SUC differentially regulate lipogenesis and adipose inflammation, leading to different metabolic outcomes. Here, ITGAX is linked to Insulin resistance.